25 May 2018 – trading update
A disappointing trading update has been released by Surgical Innovations, the designer and manufacturer of innovative medical equipment for minimally invasive surgery. There have been delays in the supply of products sourced from Meccellis Biotech SA which are distributed by the group’s subsidiary Elemental Healthcare. The shortfall in the supply is because of a change in the regulatory framework surrounding these products and is not the fault of either Surgical Innovations or Meccellis. but the impact is that revenues in the current financial year to 31 December may be £1.25m less than previously expected. The remainder of the group is not affected and the company still expects pre-tax profits to grow slightly this year. The fall in the share price has presented long term investors with an opportunity to BUY.